Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yeo Jin Choi, Yong Won Choi, Jung-woo Chae, Hwi-yeol Yun & Sooyoung Shin. (2021) Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index. Risk Management and Healthcare Policy 14, pages 1855-1867.
Read now
Read now
Maria Teresa Sartori & Paolo Prandoni. (2016) How to effectively manage the event of bleeding complications when using anticoagulants. Expert Review of Hematology 9:1, pages 37-50.
Read now
Read now
András Komócsi. (2015) Discontinuation of anticoagulant treatment: from clinical trials to medication persistence. Current Medical Research and Opinion 31:10, pages 1841-1844.
Read now
Read now
Articles from other publishers (42)
Yuya Sakuma, Takeshi Shimizu, Yuta Kurosawa, Himika Ohara, Yuki Muto, Yu Sato, Takatoyo Kiko, Akihiko Sato, Tomofumi Misaka, Akiomi Yoshihisa, Takayoshi Yamaki, Kazuhiko Nakazato, Takafumi Ishida & Yasuchika Takeishi. (2023) Impact of bleeding event for new cancer diagnosis in patients with antiplatelet therapy after percutaneous coronary intervention. Journal of Cardiology 82:6, pages 460-466.
Crossref
Crossref
Taner AKYOL. (2023) Evaluation of clopidogrel use on gastric precancerous lesions: Does it have chemopreventive effect?Mide prekanseröz lezyonlarında klopidogrel kullanımının değerlendirilmesi: Kemopreventif etkisi var mı?. Journal of Medicine and Palliative Care 4:5, pages 524-529.
Crossref
Crossref
Tomasz Górnicki, Kacper Bułdyś, Dorota Zielińska & Mariusz Chabowski. (2023) Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review. Cancers 15:10, pages 2697.
Crossref
Crossref
Simon Ladefoged Rasmussen, Christian Torp-Pedersen, Kåre Andersson Gotschalck & Ole Thorlacius-Ussing. (2023) The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study. Endoscopy 55:05, pages 444-455.
Crossref
Crossref
Ian Lancaster, Vikas Sethi, Deep Patel, Cyrus Tamboli, Elizabeth Pacer, Jeffrey Steinhoff, Meir Mizrahi & Andrew Willinger. (2023) Antithrombotics and Gastrointestinal Prophylaxis: A Systematic Review. Cardiology in Review Publish Ahead of Print.
Crossref
Crossref
Stefano Ballestri, Elisa Romagnoli, Dimitriy Arioli, Valeria Coluccio, Alessandra Marrazzo, Afroditi Athanasiou, Maria Di Girolamo, Cinzia Cappi, Marco Marietta & Mariano Capitelli. (2022) Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review. Advances in Therapy 40:1, pages 41-66.
Crossref
Crossref
David L. Madnick & Michael G. Fradley. (2022) Atrial Fibrillation and Cancer Patients: Mechanisms and Management. Current Cardiology Reports 24:10, pages 1517-1527.
Crossref
Crossref
Ratko Lasica, Milika Asanin, Lazar Djukanovic, Nebojsa Radovanovic, Lidija Savic, Marija Polovina, Sanja Stankovic, Arsen Ristic, Marija Zdravkovic, Andjelka Lasica, Jelena Kravic & Jovan Perunicic. (2022) Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application. Pharmaceuticals 15:9, pages 1146.
Crossref
Crossref
Peter Vibe Rasmussen, Frederik Dalgaard, Gunnar Hilmar Gislason, Axel Brandes, Søren Paaske Johnsen, Erik Lerkevang Grove, Christian Torp-Pedersen, Lars Dybro, Louise Harboe, Anna-Marie Bloch Münster, Lasse Pedersen, Paul Blanche, Jannik Langtved Pallisgaard & Morten Lock Hansen. (2022) Gastrointestinal bleeding and the risk of colorectal cancer in anticoagulated patients with atrial fibrillation. European Heart Journal 43:7, pages e38-e44.
Crossref
Crossref
Felicita Andreotti & Aldo Pietro Maggioni. (2022) Cancer unmasked by bleeding during anticoagulant therapy: when a problem may become an opportunity. European Heart Journal 43:7, pages e45-e47.
Crossref
Crossref
Adrian Carabineanu, Claudia Zaharia, Alexandru Blidisel, Razvan Ilina, Codruta Miclaus, Ovidiu Ardelean, Marius Preda & Octavian Mazilu. (2021) Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment. Medicina 57:10, pages 1003.
Crossref
Crossref
Doris Barcellona, L. Fenu & F. Marongiu. (2021) Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants. International Journal of Cardiology 339, pages 134-137.
Crossref
Crossref
Anastasios Papanastasiou, Antonios Morsi-Yeroyannis, Efstratios Karagiannidis, Anastasios Kartas, Ioannis Doundoulakis, Haralambos Karvounis & George Giannakoulas. (2021) Association of anticoagulant-related bleeding events with cancer detection in atrial fibrillation: A systematic review and meta-analysis. Hellenic Journal of Cardiology 62:5, pages 359-365.
Crossref
Crossref
A. L. Komarov, O. O. Shakhmatova, V. V. Korobkova, E. S. Novikova, E. V. Guskova, E. B. Yarovaya, T. V. Balachonova, A. G. Shuleshova & E. P. Panchenko. (2021) Risk factors and outcomes of gastrointestinal bleeding in patients with stable coronary artery disease: data from the observational registry of long-term antithrombotic therapy REGATTA-1. Russian Journal of Cardiology 26:6, pages 4465.
Crossref
Crossref
John W. Eikelboom, Deepak L. Bhatt, Keith A.A. Fox, Jacqueline Bosch, Stuart J. Connolly, Sonia S. Anand, Alvaro Avezum, Scott D. Berkowitz, Kelley R.H. Branch, Gilles R. Dagenais, Camilo Félix, Tomasz J. Guzik, Robert G. Hart, Aldo P. Maggioni, Eva Muehlhofer, Mukul Sharma, Olga Shestakovska & Salim Yusuf. (2021) Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. Journal of the American College of Cardiology 78:1, pages 14-23.
Crossref
Crossref
Veronica Ojetti, Angela Saviano, Mattia Brigida, Luisa Saviano, Alessio Migneco & Francesco Franceschi. (2021) A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal Bleeding. Reviews on Recent Clinical Trials 15:4, pages 309-320.
Crossref
Crossref
Ya. A. Noskov, A. S. Polyakov, E. S. Bratilova & V. V. Tyrenko. (2020) The prevention and treatment of bleeding associated with direct oral anticoagulants. Clinical Medicine (Russian Journal) 96:7, pages 491-497.
Crossref
Crossref
Sergio Raposeiras Roubín, Emad Abu Assi, Cristina Barreiro Pardal, María Cespón Fernandez, Isabel Muñoz Pousa, Rafael Cobas Paz, Jose Antonio Parada, Marta Represa Montenegro, María Melendo Miu, Sonia Blanco Prieto, Xavier Rosselló, Borja Ibañez & Andrés Íñiguez Romo. (2020) New Cancer Diagnosis After Bleeding in Anticoagulated Patients With Atrial Fibrillation. Journal of the American Heart Association 9:22.
Crossref
Crossref
Ting-Yung Chang, Yi-Hsin Chan, Chern-En Chiang, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Jo-Nan Liao, Fa-Po Chung, Tzeng-Ji Chen, Gregory Y.H. Lip, Shih-Ann Chen & Tze-Fan Chao. (2020) Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: A nationwide cohort study. Heart Rhythm 17:10, pages 1745-1751.
Crossref
Crossref
F. Radaelli, L. Fuccio, S. Paggi, C. Del Bono, J.M. Dumonceau & F. Dentali. (2020) What gastroenterologists should know about direct oral anticoagulants. Digestive and Liver Disease 52:10, pages 1115-1125.
Crossref
Crossref
Mengxia Zhang, Lin-ling Li, Qian-qian Zhao, Xiao-dong Peng, Kui Wu, Xin Li, Yan-Fei Ruan, Rong Bai, Nian Liu & Chang Sheng Ma. (2020) The Association of New-Onset Atrial Fibrillation and Risk of Cancer: A Systematic Review and Meta-Analysis. Cardiology Research and Practice 2020, pages 1-8.
Crossref
Crossref
Donald Mattison, Christopher Gravel, Daniel Krewski, Laurent Azoulay, Blánaid Hicks & Antonios Douros. (2020) Direct oral anticoagulants and oesophageal disorders: a pharmacovigilance analysis. European Journal of Clinical Pharmacology 76:7, pages 1045-1047.
Crossref
Crossref
A. L. Komarov, O. O. Shakhmatova & V. V. Korobkova. (2020) The balance of benefit and risk in prescribing antithrombotic therapy for patients with coronary artery disease. How to deal with the gastrointestinal bleeding problem?. Kardiologiia 60:7, pages 115-124.
Crossref
Crossref
Jelena Kornej, Christin S. BörschelEmelia J. Benjamin & Renate B. Schnabel. (2020) Epidemiology of Atrial Fibrillation in the 21st Century. Circulation Research 127:1, pages 4-20.
Crossref
Crossref
Sergio Raposeiras-Roubín, Emad Abu-Assi, Isabel Muñoz-Pousa, Xavier Rossello, María Cespón-Fernández, María Melendo Viu, Berenice Caneiro-Queija, Rafael Cobas-Paz, Guillermo Bastos & Andrés Iñíguez-Romo. (2020) Usefulness of Bleeding After Acute Coronary Syndromes for Unmasking Silent Cancer. The American Journal of Cardiology 125:12, pages 1801-1808.
Crossref
Crossref
John W. EikelboomStuart J. ConnollyJacqueline BoschOlga ShestakovskaVictor AboyansMarco AlingsSonia S. AnandAlvaro AvezumScott D. BerkowitzDeepak L. BhattNancy Cook-BrunsCamilo FelixKeith A.A. FoxRobert G. HartAldo P. MaggioniPaul MoayyediMartin O’DonnellLars RydénPeter VerhammePetr WidimskyJun ZhuSalim Yusuf. (2019) Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis. Circulation 140:18, pages 1451-1459.
Crossref
Crossref
Gordon Chu, Henri H. Versteeg, Arie J. Verschoor, Serge A. Trines, Martin E.W. Hemels, Cihan Ay, Menno V. Huisman & Frederikus A. Klok. (2019) Atrial fibrillation and cancer – An unexplored field in cardiovascular oncology. Blood Reviews 35, pages 59-67.
Crossref
Crossref
Yu-Feng Hu, Shih-Lin Chang, Chang-Ming Chern, Cheng-Hsueh Wu, Yenn-Jiang Lin, Li-Wei Lo, Tze-Fan Chao, Fa-Po Chung, Jo-Nan Liao, Ting-Yung Chang, Ting-Chun Huang, Cheng-I Wu, Chih-Min Liu, Simon Salim, Jennifer Jeanne Vicera, Le Phat Tai & Shih-Ann Chen. (2019) Bleeding and New-Onset Cancers in Patients With Atrial Fibrillation Receiving Nonvitamin K Antagonist Oral Anticoagulants. The American Journal of Cardiology 123:5, pages 782-786.
Crossref
Crossref
Nicklas Vinter, Amanda M. S. Christesen, Morten Fenger‐Grøn, Anne Tjønneland & Lars Frost. (2018) Atrial Fibrillation and Risk of Cancer: A Danish Population‐Based Cohort Study. Journal of the American Heart Association 7:17.
Crossref
Crossref
Chi-Sheng Hung, Chia-Hsuin Chang, Jou-Wei Lin, Yi-Lwun Ho & Ming-Fong Chen. (2018) The association between new onset atrial fibrillation and incident cancer—A nationwide cohort study. PLOS ONE 13:6, pages e0199901.
Crossref
Crossref
Ki Hong Lee, Boyoung Joung, So-Ryoung Lee, You Mi Hwang, Junbeom Park, Yong Soo Baek, Yae Min Park, Jin-Kyu Park, Hwan Cheol Park, Hyung Wook Park, Young Soo Lee & Kee Joon Choi. (2018) 2018 KHRS Expert Consensus Recommendation for Oral Anticoagulants Choice and Appropriate Doses: Specific Situation and High Risk Patients. The Korean Journal of Medicine 93:2, pages 110-132.
Crossref
Crossref
Luis Colín & Manlio F. Márquez. (2018) Occult gastrointestinal disease unmasked by direct oral anticoagulants used for the prevention of atrial fibrillation. Archivos de Cardiología de México 88:2, pages 161-162.
Crossref
Crossref
Hideki Koike, Tadashi Fujino, Makiko Koike, Shintaro Yao, Katsuya Akitsu, Masaya Shinohara, Hitomi Yuzawa, Takeya Suzuki & Takanori Ikeda. (2018) Bleeding with oral anticoagulant dabigatran is highly associated with occult cancers in atrial fibrillation patients. Future Cardiology 14:1, pages 27-36.
Crossref
Crossref
Marcelo Sanmartín-Fernández & Domingo Marzal-Martín. (2016) Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice: Focus on Rivaroxaban in Stroke Prevention in Patients With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis 23:7, pages 711-724.
Crossref
Crossref
Kathryn F. Flack, Jay Desai, Jennifer M. Kolb, Prapti Chatterjee, Lars C. Wallentin, Michael Ezekowitz, Salim Yusuf, Stuart Connolly, Paul Reilly, Martina Brueckmann, John Ilgenfritz & James Aisenberg. (2017) Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation. Clinical Gastroenterology and Hepatology 15:5, pages 682-690.
Crossref
Crossref
Federico Pasin, Sophie Testa, Pietro Capone, Elena Iiritano & Roberto Grassia. (2017) Gastrointestinal bleeding during Direct Oral AntiCoagulants-anticoagulant therapy. Is there nothing so bad that is not good for something?. European Journal of Internal Medicine 39, pages e25-e26.
Crossref
Crossref
Ka-Shing Cheung & Wai K Leung. (2017) Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management. World Journal of Gastroenterology 23:11, pages 1954.
Crossref
Crossref
Hee Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Jong-Youn Kim, Hui-Nam Pak, Moon-Hyoung Lee & Boyoung Joung. (2017) Clinical Significance of Hematuria in Atrial Fibrillation With Oral Anticoagulation Therapy. Circulation Journal 81:2, pages 158-164.
Crossref
Crossref
Anders Gorst-Rasmussen, Gregory Y. H. Lip & Torben Bjerregaard Larsen. (2016) Rivaroxaban versus warfarin and dabigatran in atrial fibrillation: comparative effectiveness and safety in Danish routine care. Pharmacoepidemiology and Drug Safety 25:11, pages 1236-1244.
Crossref
Crossref
Joanna M. Peloquin, Siamak M. Seraj, Lindsay Y. King, Emily J. Campbell, Ashwin N. Ananthakrishnan & James M. Richter. (2016) Diagnostic and Therapeutic Yield of Endoscopy in Patients with Elevated INR and Gastrointestinal Bleeding. The American Journal of Medicine 129:6, pages 628-634.
Crossref
Crossref
Hans-Christoph Diener, James Aisenberg, Jack Ansell, Dan Atar, Günter Breithardt, John Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Jonathan L. Halperin, Stefan H. Hohnloser, Elaine M. Hylek, Paulus Kirchhof, Deirdre A. Lane, Freek W.A. Verheugt, Roland Veltkamp & Gregory Y.H. Lip. (2016) Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. European Heart Journal, pages ehw069.
Crossref
Crossref
Jamshed Dalal, Abhay Bhave, Abraham Oomman, Amit Vora, Anil Saxena, Dhiman Kahali, Fali Poncha, D.S. Gambhir, Jaydip Ray Chaudhuri, Nakul Sinha, Saumitra Ray, S.S. Iyengar, Suvro Banerjee & Upendra Kaul. (2015) The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants. Indian Heart Journal 67, pages S13-S34.
Crossref
Crossref